| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |